Posterior Epistaxis Nasal Pack 

  • Author: Eric Goralnick, MD; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Jun 7, 2011
 

Overview

Background

Epistaxis is a common problem in the emergency department (ED). Although it usually is relatively benign, it can produce serious, life-threatening situations. Up to 60% of the population is estimated to have had at least 1 episode of epistaxis at some point in their lives. Of this group, 6% seek medical care to treat epistaxis, with 1.6 in 10,000 requiring hospitalization.[1]

A patient with epistaxis must be evaluated expediently.[2, 3, 4] All patients with epistaxis require a thorough examination and control of the bleeding. Epistaxis that has resolved still requires management to prevent rebleeding.[5]

Ten percent of epistaxes are posterior, exhibiting massive bleeding that is initially bilateral. Posterior epistaxis may present in ways that suggest a more inferiorly located site of bleeding from the aerodigestive tract (eg, hemoptysis, melena, anemia, or just nausea). A posterior source of the bleeding must be sought when epistaxis is bilateral, brisk, and not controlled with anterior nasal packing.

Posterior epistaxis is usually treated by an otolaryngologist, but an emergency practitioner may be called upon to treat this condition in a medical environment with few support services.

A focused history aids the clinician in managing the acutely bleeding patient. This history should include some or all of the following questions:

  • Which side is bleeding?
  • Which side was bleeding initially?
  • What is the estimated amount of blood loss?
  • Is it recurrent?
  • Is it in the pharynx?
  • Has any trauma recently occurred?
  • Are symptoms of hypovolemia present?
  • What are the patient’s past medical history and current medications (eg, aspirin, warfarin)?[6]

The bleeding site of a posterior epistaxis is either posterior to the middle turbinate or at the posterior superior aspect of the nasal cavity. Branches of the sphenopalatine artery supply the blood for such an epistaxis (see the image below). The vast majority of posterior bleeding sites originate from the septum.[7]

Nasal vascular anatomy

Nasal vascular anatomy. Nasal vascular anatomy.

As with any unstable patient, initial management begins by assessing the ABCs (A irway, B reathing, and C irculation). Next, the source of the bleed should be identified by a thorough examination of the nasopharynx.

A posterior pack is placed to occlude the choanal arch and, in conjunction with an anterior nasal pack, provide hemostasis. Posterior packing can be accomplished with gauze, a Foley catheter, a nasal sponge/tampon, or an inflatable nasal balloon catheter. Posterior packing is very uncomfortable and may necessitate procedural sedation. An anterior nasal pack is always required on the side of a posterior pack, and a contralateral nasal pack is strongly encouraged to maintain the septum midline.[5]

For more information, see Epistaxis, Management of Acute Epistaxis, and Anterior Epistaxis Nasal Pack.

Indications

Indications for posterior nasal packing include the following:

  • Failure of anterior packing
  • Reliable or high suspicion of posterior bleeding (patient spitting out blood, older patient with atherosclerosis, no visible anterior bleeding site)
  • Patient with bleeding diathesis (hereditary hemorrhagic telangiectasia,[8]von Willebrand disease, hemophilia, anticoagulation, antiplatelet therapy) - Each of these states makes hemostatic control much more difficult, and each has its set of additional specific targeted therapies.

Temporizing measures until more definitive therapies are obtained include endoscopic ligation by an otolaryngologist or endovascular ligation by an interventional radiologist.

Contraindications

Posterior nasal packing should not be performed in the presence of facial trauma that may include nasal bone and cribriform plate fractures. (See Facial Fractures.)

If the patient is in shock, has altered mental status, or is otherwise not protecting the airway, the airway must be controlled before any nasal packing is attempted.

Next

Technique

Overview

Good lighting is paramount. A head lamp is optimal, but a reasonable alternative is an overhead lamp.

Have the patient blow his or her nose to expel any clot. Perform a thorough anterior nasal examination to rule out an anterior bleeding source. A brisk posterior bleed may have some anterior flow but predominantly manifests with posterior oropharyngeal blood flow.

Go to Surgery for Pediatric Epistaxis for complete information on this topic.

Topical Anesthesia and Vasoconstriction

Have the patient nasally insufflate a topical vasoconstrictor, such as oxymetazoline or phenylephrine. To provide anesthesia, add 2% lidocaine solution to the vasoconstrictor first, and then have the patient inhale the combination.

Double-Balloon Approach

Apply mupirocin (Bactroban) nasal ointment 2% to the double-balloon catheter, and advance the device completely into the nostril. Inflate the posterior balloon with up to 7-10 mL of sterile water. Withdraw the catheter until posterior balloon seats. The balloon stops at the posterior nasal cavity. Inflate the anterior balloon with up to 15-30 mL of sterile water.

Apply padding (eg, Xeroform wrap, iodoform strips) to prevent alar necrosis. Leave the balloons in place for 3-5 days, until coagulopathy and hypertension have been controlled.

Foley Catheter Approach

Apply mupirocin nasal ointment 2% to the Foley catheter, and insert the device into the nostril. Visualize the catheter tip in the back of the throat. Inflate the balloon with up to 10 mL of sterile water. (Do not inflate the balloon to its full 30-mL capacity.) Withdraw the balloon gently until it seats posteriorly.

Pack the anterior nasal cavity with a balloon device, nasal tampon (eg, Rhino Rocket), or layered ribbon gauze. Apply a padded umbilical clamp across the catheter to prevent alar necrosis and to keep the balloon from dislodging.

Posterior packing with 10F Foley catheter

Posterior packing with 10F Foley catheter. Posterior packing with 10F Foley catheter.
Previous
Next

Preparation

Anesthesia

Topical anesthetics include lidocaine (2% solution) (see the image below).

Lidocaine, 2%. Lidocaine, 2%.

For more information, see Topical Anesthesia.

Vasoconstrictors include the following:

  • Epinephrine (1:1000 or 1:10,000) (see the images below)
  • Phenylephrine (Neo-Synephrine Fast-Acting Nasal)
  • Oxymetazoline (Afrin, Neo-Synephrine 12-hour Maximum Strength Nasal)Epinephrine 1:1000. Epinephrine 1:1000. Epinephrine 1:10,000. Epinephrine 1:10,000.

Equipment

Equipment includes the following:

  • Gloves
  • Tape
  • Tongue depressors
  • Nasal speculum
  • Posterior packing (balloon methods) - Commercially produced double-balloon tampon (see the first image below); Foley catheter, 10-14 French with a 30-mL balloon (see the second image below)
  • Posterior packing (gauze method) - Silk suture material, 0 gauge; gauze squares, 4 × 4; catheter (Foley or some other type; not to be inflated); hemostats
  • Commercially produced anterior nasal tampon
  • Absorbable gelatin (Gelfoam)
  • Oxidized cellulose (Surgicel)Medtronic Xomed double-balloon catheter. Medtronic Xomed double-balloon catheter. Foley catheter, 10F. Foley catheter, 10F.

Positioning

Place patient in the upright position (see the image below) unless hemodynamic instability prevents this positioning.

Proper positioning of patient. Proper positioning of patient.
Previous
Next

Post-Procedure

Postoperative Care

Antibiotics may be prescribed. Agents that cover Staphylococcus species (eg, cephalexin, amoxicillin, ampicillin) can prevent sinusitis and toxic shock syndrome.

Admit all patients with posterior packing to the hospital for observation. Reflex bradydysrhythmia can develop because of stimulation of the deep posterior oropharynx by the packing. Airway compromise may develop. Posterior packing should be removed in 72-96 hours.

Complications

Potential complications include the following:

  • Sinusitis
  • Nasal septal pressure necrosis
  • Abscesses
  • Neurogenic syncope
  • Toxic shock syndrome
  • Persistent bleeding and restart of bleeding, in spite of above interventions
Previous
 
Contributor Information and Disclosures
Author

Eric Goralnick, MD  Staff Physician, Department of Emergency Medicine, Yale-New Haven Hospital

Eric Goralnick, MD is a member of the following medical societies: American College of Emergency Physicians, Emergency Medicine Residents Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Prajoy P Kadkade, MD  Assistant Professor of Otolaryngology, Albert Einstein College of Medicine; Attending Physician, Department of Otolaryngology and Communicative Disorders, Director of Otolaryngology, North Shore University Hospital, North Shore-Long Island Jewish Hospital System

Prajoy P Kadkade, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and Medical Society of the State of New York

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Luis M Lovato, MD  Associate Clinical Professor, University of California, Los Angeles, David Geffen School of Medicine; Director of Critical Care, Department of Emergency Medicine, Olive View-UCLA Medical Center

Luis M Lovato, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Scott Bailey, MD,to the development and writing of the source article.

References
  1. Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg. Mar 2006;64(3):511-8. [Medline].

  2. Frazee TA, Hauser MS. Nonsurgical management of epistaxis. J Oral Maxillofac Surg. Apr 2000;58(4):419-24. [Medline].

  3. Schaitkin B, Strauss M, Houck JR. Epistaxis: medical versus surgical therapy: a comparison of efficacy, complications, and economic considerations. Laryngoscope. Dec 1987;97(12):1392-6. [Medline].

  4. Tintinalli JE, Ruiz E, Krome RL, eds. Nasal emergencies and sinusitis. In: Emergency Medicine: A Comprehensive Study Guide. 4th. New York: McGraw-Hill, Health Professions Division; 1996:1083-93.

  5. Reichman E, et al. Emergency Medicine Procedures. McGraw Hill; 2004.

  6. Leong SC, Roe RJ, Karkanevatos A. No frills management of epistaxis. Emerg Med J. Jul 2005;22(7):470-2. [Medline].

  7. Chiu TW, McGarry GW. Prospective clinical study of bleeding sites in idiopathic adult posterior epistaxis. Otolaryngol Head Neck Surg. Sep 2007;137(3):390-3. [Medline].

  8. Saba HI, Morelli GA, Logrono LA. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med. Jun 23 1994;330(25):1789-90. [Medline].

Previous
Next
 
Frazier suction catheters.
Epistaxis tray.
Foley catheter, 8F.
Foley catheter, 8F.
Nasal vascular anatomy.
Bayonet forceps.
Lidocaine, 2%.
Cocaine, 4%.
Epinephrine 1:1000.
Foley catheter, 10F.
Epinephrine 1:10,000.
Medtronic Xomed double-balloon catheter.
Proper positioning of patient.
Posterior packing with 10F Foley catheter.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.